Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVON trial of intravenous ferric carboxymaltose versus oral ferrous sulphate for iron deficiency anemia in pregnancy
PACTR202012843695208Phase 3Completed
- Sponsor
- University of Lagos
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in iron deficiency anemia (IDA) comparing Intravenous ferric carboxymaltose with Oral ferrous sulphate (2 arms). Primary endpoints: Maternal anemia prevalence at 36 weeks' gestation and Preterm birth incidence. Started Jan 2021; status: completed.
02
Drugs
ferric carboxymaltoseferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on PACTR202012843695208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202012843695208.